Tumor Type-Agnostic Treatment and the Future of Cancer Therapy Luis E. RaezEdgardo S. Santos Editorial 09 October 2018 Pages: 541 - 544
TRK Inhibition: A New Tumor-Agnostic Treatment Strategy Shivaani KummarUlrik N. Lassen Review Article Open access 02 October 2018 Pages: 545 - 556
Targeted Therapies in the Treatment of Sarcomas Brianna HoffnerAnthony D. EliasVictor M. Villalobos Review Article 24 August 2018 Pages: 557 - 565
Treatment of Advanced Merkel Cell Carcinoma: Current Therapeutic Options and Novel Immunotherapy Approaches Daniela FemiaNatalie PrinziSara Pusceddu Review Article 02 August 2018 Pages: 567 - 582
Targeting Toll-Like Receptors for Cancer Therapy Marc J. BraunsteinJohn KucharczykSylvia Adams Review Article 18 September 2018 Pages: 583 - 598
Immunological Correlates of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma Alice TzengC. Marcela Diaz-MonteroPetros Grivas Original Research Article 28 September 2018 Pages: 599 - 609
Immediate Progressive Disease in Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab: a Multi-Institution Retrospective Study Hiroki IshiharaTsunenori KondoKazunari Tanabe Original Research Article 19 September 2018 Pages: 611 - 619
EGFR Amplification and Sensitizing Mutations Correlate with Survival in Lung Adenocarcinoma Patients Treated with Erlotinib (MutP-CLICaP) Alejandro Ruiz-PatiƱoChristian David CastroOn behalf of the Latin-American Consortium for the Investigation of Lung Cancer (CLICaP) Original Research Article 04 October 2018 Pages: 621 - 629
Characteristics and Response to Crizotinib in ALK-Rearranged, Advanced Non-Adenocarcinoma, Non-Small Cell Lung Cancer (NA-NSCLC) Patients: a Retrospective Study and Literature Review Bo ZhangYanwei ZhangBaohui Han Original Research Article 14 September 2018 Pages: 631 - 639
Everolimus Exposure and Early Metabolic Response as Predictors of Treatment Outcomes in Breast Cancer Patients Treated with Everolimus and Exemestane Annelieke E. C. A. B. WillemsenLioe-Fee de Geus-OeiNielka P. van Erp Original Research Article Open access 27 September 2018 Pages: 641 - 648
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer Roberto IacovelliChiara CiccareseGiampaolo Tortora Original Research Article 30 August 2018 Pages: 649 - 655
Vitamin D Deficiency has a Negative Impact on Cetuximab-Mediated Cellular Cytotoxicity against Human Colon Carcinoma Cells Lorenzo MortaraMarzia B. GariboldiLeonardo Campiotti Original Research Article 09 August 2018 Pages: 657 - 665
Correction to: Medical Treatment Options for Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer Suffering from Brain Metastases and/or Leptomeningeal Disease Maximilian Hochmair Correction 02 October 2018 Pages: 667 - 667